Mechanisms underlying gut dysfunction in a murine model of chronic parasitic infection

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 6, 2010, Pages

  Motomura, Yasuaki ^a,b   Khan, Waliul I ^a   El Sharkawy, Rami T ^a   Verma Gandhu, Monica ^a   Grencis, Richard K ^c   Collins, Stephen M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ASO IIZUKA HOSPITAL   (Japan)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Animal model; Inflammation; Irritable bowel syndrome; Motility; Th1 cytokine

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; MYELOPEROXIDASE; OXANTEL EMBONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EOSINOPHIL; ERADICATION THERAPY; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATION; INNERVATION; IRRITABLE COLON; MALE; MOUSE; MUSCLE CONTRACTILITY; MUSCLE DISEASE; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; TRICHURIASIS; TRICHURIS; TRICHURIS MURIS;

ADRENAL CORTEX HORMONES; ANIMALS; ANTHELMINTICS; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; COLON; DEXAMETHASONE; GASTROINTESTINAL DISEASES; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED AKR; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PEROXIDASE; PYRANTEL PAMOATE; TRICHURIASIS; TRICHURIS;

EID: 78649738501     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00324.2010     Document Type: Article

References (34)

1. Anand AC, Reddy PS, Saiprasad GS, Kher SK. Does non-dysenteric intestinal amoebiasis exist? Lancet 349: 89-92, 1997.
2. Antia FP, Desai HG, Chaphekar PM, Chhabra RH, Swami RH, Borkar AV. Bacterial flora in intestinal amoebiasis. Gut 6: 588-590, 1965.
3. Atoba MA. Irritable bowel syndrome in Nigerians. Dig Dis Sci 33: 414-416, 1988.
4. Barbara G, De Giorgio R, Deng Y, Vallance B, Blennerhassett P, Collins SM. Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology 120: 1729-1736, 2001.
5. Barbara G, Vallance BA, Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 113: 1224-1322, 1997.
6. Bercik P, Wang L, Verdu EF, Mao YK, Blennerhassett P, Khan WI, Kean I, Tougas G, Collins SM. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology 127: 179-187, 2004.
7. Benenson AS, Garfinkel BT, Oseasohn RO. The symptom-complex of non-dysenteric intestinal amebiasis. Gastroenterology 31: 246-250, 1956.
8. Blennerhassett P, Collins SM. TH-1 and TH-2 cytokines differ in their effects on smooth muscle contractility in the rodent gut (Abstract). Gastroenterology 110: A867, 1996.
9. Collins SM, Blennerhassett PA, Blennerhassett MG, Vermillion DL. Impaired acetylcholine release from the myenteric plexus of Trichinella-infected rats. Am J Physiol Gastrointest Liver Physiol 257: G898-G903, 1989.
10. Di Sebastiano P, Grossi L, Di Mola FF, Angelucci D, Friess H, Marzio L, Innocenti P, Buchler MW. SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Dig Dis Sci 44: 439-444, 1999.
11. Else KJ, Hultner L, Grencis RK. Cellular immune responses to the murine nematode parasite Trichuris muris. II. Differential induction of TH-cell subsets in resistant versus susceptible mice. Immunology 75: 232-237, 1992.
12. Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 18: 436-499, 1999.
13. Grossi L, McHugh K, Collins SM. On the specificity of altered muscle function in experimental colitis in rats. Gastroenterology 104: 1049-1056, 1993.
14. Gwee KA. Irritable bowel syndrome in developing countries-a disorder of civilization or colonization? Neurogastroenterol Motil 17: 317-324, 2005.
15. Hussain R, Jaferi W, Zuberi S, Baqai R, Abrar N, Ahmed A, Zaman V. Significantly increased IgG2 subclass antibody levels to Blastocystis hominis in patients with irritable bowel syndrome. Am J Trop Med Hyg 56: 301-306, 1997.
16. Jain AP, Gupta OP, Jajoo UN, Sidhwa HK. Clinical profile of irritable bowel syndrome at a rural based teaching hospital in central India. J Assoc Physicians India 39: 385-386, 1991.
17. Khan WI, Richard M, Akiho H, Blennerhasset PA, Humphreys NE, Grencis RK, Van Snick J, Collins SM. Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections. Infect Immun 71: 2430-2438, 2003.
18. Kwan AC, Hu WH, Chan YK, Yeung YW, Lai TS, Yuen H. Prevalence of irritable bowel syndrome in Hong Kong. J Gastroenterol Hepatol 17: 1180-1186, 2002.
19. Lammas DA, Wakelin D, Mitchell LA, Tuohy M, Else KJ, Grencis RK. Genetic influences upon eosinophilia and resistance in mice infected with Trichinella spiralis. Parasitology 105: 117-124, 1992.
20. Lau EM, Chan FK, Ziea ET, Chan CS, Wu JC, Sung JJ. Epidemiology of irritable bowel syndrome in Chinese. Dig Dis Sci 47: 2621-2624, 2002.
21. Lule GN, Amayo EO. Irritable bowel syndrome in Kenyans. East Afr Med J 79: 360-363, 2002.
22. Marion R, Baishanbo A, Gargala G, Franccois A, Ducrotte P, Duclos C, Fioramonti J, Jacques Ballet J, Favennec L. Transient neonatal Cryptosporidium parvum infection triggers long-term jejunal hypersensitivity to distension in immunocompetent rats. Infect Immun 74: 4387-4389, 2006.
23. Miller MJ, Gilani A. The clinical significance of non-dysenteric intestinal amoebiasis. Trans R Soc Trop Med Hyg 45: 131-136, 1951.
24. Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 318: 565-566, 1999.
25. Saito YA, Talley NJ, Melton J, Fett S, Zinsmeister AR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil 15: 687-694, 2003.
26. Singh S, Raju GV, Samantaray JC. Parasitic gut flora in a north Indian population with gastrointestinal symptoms. Trop Gastroenterol 14: 104-108, 1993.
27. Sinha P, Ghoshal UC, Choudhuri G, Naik S, Ayyagari A, Naik SR. Does Entamoeba histolytica cause irritable bowel syndrome? Indian J Gastroenterol 16: 130-133, 1997.
28. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 124: 1662-1671, 2003.
29. Tungtrongchitr A, Manatsathit S, Kositchaiwat C, Ongrotchanakun J, Munkong N, Chinabutr P, Leelakusolvong S, Chaicumpa W. Blastocystis hominis infection in irritable bowel syndrome patients. Southeast Asian J Trop Med Public Health 35: 705-710, 2004.
30. Yakoob J, Jafri W, Jafri N, Khan R, Islam M, Beg MA, Zaman V. Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. Am J Trop Med Hyg 70: 383-385, 2004. (Pubitemid 38525549)
31. Vermillion DL, Collins SM. Increased responsiveness of jejunal longitudinal muscle in Trichinella-infected rats. Am J Physiol Gastrointest Liver Physiol 254: G124-G129, 1988.
32. Verdu EF, Bercik P, Bergonzelli GE, Huang XX, Blennerhasset P, Rochat F, Fiaux M, Mansourian R, Corthesy-Theulaz I, Collins SM. Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology 127: 826-837, 2004.
33. Verdu EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, Mao Y, Wang L, Rochat F, Collins SM. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55: 182-190, 2006.
34. Wang H, Steeds J, Motomura Y, Deng Y, Verma-Gandhu M, El-Sharkawy RT, McLaughlin JT, Grencis RK, Khan WI. CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection. Gut 56: 949-957, 2007.